Corcept Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CORT and other ETFs, options, and stocks.About CORT
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B.
CEOJoseph K. Belanoff
CEOJoseph K. Belanoff
Employees500
Employees500
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded1998
Founded1998
Employees500
Employees500
CORT Key Statistics
Market cap8.10B
Market cap8.10B
Price-Earnings ratio66.90
Price-Earnings ratio66.90
Dividend yield—
Dividend yield—
Average volume777.16K
Average volume777.16K
High today$77.08
High today$77.08
Low today$74.89
Low today$74.89
Open price$75.37
Open price$75.37
Volume82.37K
Volume82.37K
52 Week high$117.33
52 Week high$117.33
52 Week low$40.15
52 Week low$40.15
CORT News
Simply Wall St 3d
The Bull Case For Corcept Therapeutics Could Change Following FDA Acceptance of Relacorilant Application – Learn WhyCorcept Therapeutics recently announced that the FDA has accepted its New Drug Application for relacorilant as a potential treatment for patients with platinum-...
People also own
Based on the portfolios of people who own CORT. This list is generated using Robinhood data, and it’s not a recommendation.